Zuber Lawler's Assessment and Advice on Consolidation at Benzinga's Cannabis Capital Conference

Zuber Lawler has been representing leading cannabis companies for 14 years handling initial public offerings (IPOs), M&As, finance, intellectual property, FDA and other regulatory work and litigation, in addition to representing a long list of iconic Fortune 500 companies, global funds and governmental entities in their international transactions. 
Despite the country’s change in administration and widespread talk of federal legalization, the cannabis industry is complex. However, Zuber Lawler provides trusted and reliable legal representation to mitigate the complexity. 
Well Decorated
Zuber Lawler’s accomplishments are many. The firm was recently named “Cannabis Law Firm of the Year” by Marijuana Venture Magazine and it obtained the second-ever-issued U.S. plant patent for a cannabis strain — as well as U.S. utility patents on cannabis processes, machines and formulations. In addition, the firm obtained the first-ever issued “Generally Recognized as Safe” designation from the FDA for hemp seeds in foods. 

Related Keywords

Zuber Lawler ,Janet Jackim ,Jeff Zuber ,Josh Lawler ,Cannabis Law Firm Of The Year ,Jazz Pharmaceuticals ,Ceres Acquisition Corp ,Gw Pharmaceuticals ,Law Firm ,Marijuana Venture Magazine ,Cannabis Capital Conference ,Ceres Acquisition ,Engineering Cannabisdeals ,Avoid Common Contract Pitfalls ,Partner Janet Jackim ,ஜுபேர் சட்டத்தரணி ,ஜெஃப் ஜுபேர் ,ஜோஷ் சட்டத்தரணி ,கஞ்சா சட்டம் நிறுவனம் ஆஃப் தி ஆண்டு ,ஜாஸ் மருந்துகள் ,சிஇஆர்இஎஸ் கையகப்படுத்தல் கார்ப் ,க்வ் மருந்துகள் ,சட்டம் நிறுவனம் ,மரிஜுவானா துணிகர பத்திரிகை ,கஞ்சா மூலதனம் மாநாடு ,சிஇஆர்இஎஸ் கையகப்படுத்தல் ,